Government has approved the emergency use of the Corbevax and Covovax vaccines and anti-viral pill Molnupiravir

Government has approved the emergency use of the Corbevax and Covovax vaccines and anti-viral pill Molnupiravir.

Government announced  that the approved the emergency use of two Covid-19 vaccines on Tuesday  - Corbevax and Covovax - and Molnupiravir, an anti-viral pill.

Central Health Minister Mansukh Mandaviya said on Tuesday: "The Central Drug Standard Control Organisation (CDSCO) has approved the emergency control of the Corbevax and Covovax vaccines, and anti-viral drug Molnupiravir to further strengthen the fight against Covid-19. "

Congratulations India 🇮🇳

Further strengthening the fight against COVID-19, CDSCO, @MoHFW_INDIA has given 3 approvals in a single day for:

- CORBEVAX vaccine
- COVOVAX vaccine
- Anti-viral drug Molnupiravir

For restricted use in emergency situation. (1/5)

— Dr Mansukh Mandaviya (@mansukhmandviya) December 28, 2021

 The Corbevax vaccine is India's first domestically developed RBD protein sub-unit vaccine against Covid-19, manufactured by Hyderabad-based Biological-E.

Congratulations India 🇮🇳

Further strengthening the fight against COVID-19, CDSCO, @MoHFW_INDIA has given 3 approvals in a single day for:

- CORBEVAX vaccine
- COVOVAX vaccine
- Anti-viral drug Molnupiravir

For restricted use in emergency situation. (1/5)

— Dr Mansukh Mandaviya (@mansukhmandviya) December 28, 2021

The nanoparticle antibody, Covovax, will be made by Pune-based firm Serum Institute of India, the ministries said on Tuesday.

Mandaviya said Antiviral drug, Molnupravir,it will now be manufactured by 13 companies in India.For emergency use in emergency situations for the treatment of adult patients and those at high risk of disease progression.

Praising Prime Minister Narendra Modi, the Health Minister said that the Prime Minister has led the fight against the epidemic from the front. "All of these approvals will further strengthen the global fight against the epidemic. Our pharmaceutical industry is an asset to the entire world," Mandavia said.

Praising Prime Minister Narendra Modi, the Health Minister said that the Prime Minister was leading the fight against Covid 19. "These approvals will further strengthen the global war on pandamic. Our pharmaceutical industry is a resource for the whole world," Mandavia said.

The expert panel of the country's Central Drug Commission has recommended that the Serum Institute of India's Serum Covid 19 vaccine Covovax and the Biological E vaccine Corbevax be approved for emergency use with certain conditions, official sources said.

The CDSCO's Covid-19 Course Subject Expert Panel (SEC) on Monday recommended approval for the production and marketing of Covid tablet Molnupravir for limited crisis use for the treatment of adult patients with an additional SPO2 93% and higher risk. . The course of the disease depends on the specific conditions, including hospitalization or passing.